| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein decrotonylase activity | 6.39e-07 | 5 | 81 | 3 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 6.39e-07 | 5 | 81 | 3 | GO:0160009 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 1.22e-04 | 24 | 81 | 3 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 1.39e-04 | 25 | 81 | 3 | GO:0033558 | |
| GeneOntologyMolecularFunction | deacetylase activity | 5.70e-04 | 40 | 81 | 3 | GO:0019213 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRAF3IP2 HDAC3 PARP10 AMER1 UBR5 KLHDC3 FANCI KCTD10 HDAC8 USP7 EIPR1 DCAF4 VCP | 1.77e-05 | 811 | 82 | 13 | GO:0016567 |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 3.98e-05 | 158 | 82 | 6 | GO:0032006 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRAF3IP2 HDAC3 PARP10 AMER1 UBR5 KLHDC3 FANCI KCTD10 HDAC8 USP7 EIPR1 DCAF4 VCP | 4.82e-05 | 893 | 82 | 13 | GO:0032446 |
| GeneOntologyBiologicalProcess | DNA repair | 5.00e-05 | 648 | 82 | 11 | GO:0006281 | |
| GeneOntologyBiologicalProcess | intracellular transport | TRAF3IP2 HDAC3 SETD2 MDN1 MIA2 UBR5 ENTR1 USP7 IPO13 HRC SCRIB EIPR1 ANKRD50 BBS12 VCP PCNT KPNB1 | 6.83e-05 | 1496 | 82 | 17 | GO:0046907 |
| GeneOntologyBiologicalProcess | DNA metabolic process | DPF1 HINFP PARP10 LIG1 SETD2 MEIOC UBR5 KLHDC3 FANCI HDAC8 USP7 POLQ MAPKAPK5 VCP | 8.46e-05 | 1081 | 82 | 14 | GO:0006259 |
| GeneOntologyBiologicalProcess | TOR signaling | 8.47e-05 | 181 | 82 | 6 | GO:0031929 | |
| GeneOntologyBiologicalProcess | translesion synthesis | 1.47e-04 | 26 | 82 | 3 | GO:0019985 | |
| GeneOntologyBiologicalProcess | cell cycle process | DPF1 HINFP HDAC3 LIG1 TMEM67 SETD2 MYBBP1A KIF2B MEIOC KLHDC3 ENTR1 HDAC8 NCAPH VCP PCNT KPNB1 | 1.52e-04 | 1441 | 82 | 16 | GO:0022402 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRAF3IP2 HDAC3 PARP10 AMER1 UBR5 KLHDC3 FANCI KCTD10 HDAC8 USP7 EIPR1 DCAF4 VCP | 1.64e-04 | 1009 | 82 | 13 | GO:0070647 |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte proliferation | 2.32e-04 | 6 | 82 | 2 | GO:0003419 | |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | 2.54e-04 | 314 | 82 | 7 | GO:0032386 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.69e-04 | 421 | 82 | 8 | GO:0060562 | |
| Domain | DUF3377 | 3.13e-07 | 4 | 81 | 3 | PF11857 | |
| Domain | His_deacetylse_1 | 3.13e-07 | 4 | 81 | 3 | IPR003084 | |
| Domain | Pept_M10A_metallopeptidase_C | 3.13e-07 | 4 | 81 | 3 | IPR021805 | |
| Domain | Hist_deacetyl | 1.26e-05 | 11 | 81 | 3 | PF00850 | |
| Domain | His_deacetylse_dom | 1.26e-05 | 11 | 81 | 3 | IPR023801 | |
| Domain | - | 1.26e-05 | 11 | 81 | 3 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.26e-05 | 11 | 81 | 3 | IPR000286 | |
| Domain | Hemopexin_CS | 5.11e-05 | 17 | 81 | 3 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 6.12e-05 | 18 | 81 | 3 | IPR016293 | |
| Domain | PG_binding_1 | 8.49e-05 | 20 | 81 | 3 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 8.49e-05 | 20 | 81 | 3 | IPR002477 | |
| Domain | Hemopexin-like_dom | 1.31e-04 | 23 | 81 | 3 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 1.31e-04 | 23 | 81 | 3 | IPR018487 | |
| Domain | M10A_MMP | 1.31e-04 | 23 | 81 | 3 | IPR033739 | |
| Domain | Hemopexin | 1.31e-04 | 23 | 81 | 3 | PF00045 | |
| Domain | HEMOPEXIN | 1.31e-04 | 23 | 81 | 3 | PS00024 | |
| Domain | - | 1.31e-04 | 23 | 81 | 3 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 1.31e-04 | 23 | 81 | 3 | PS51642 | |
| Domain | HX | 1.31e-04 | 23 | 81 | 3 | SM00120 | |
| Domain | Pept_M10A | 1.31e-04 | 23 | 81 | 3 | IPR021190 | |
| Domain | Peptidase_M10 | 1.49e-04 | 24 | 81 | 3 | PF00413 | |
| Domain | ZnMc | 2.65e-04 | 29 | 81 | 3 | SM00235 | |
| Domain | Peptidase_Metallo | 2.65e-04 | 29 | 81 | 3 | IPR006026 | |
| Domain | CYSTEINE_SWITCH | 7.44e-04 | 41 | 81 | 3 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 8.56e-04 | 43 | 81 | 3 | IPR001818 | |
| Domain | IMPORTIN_B_NT | 1.63e-03 | 14 | 81 | 2 | PS50166 | |
| Domain | Ferritin-like_SF | 1.63e-03 | 14 | 81 | 2 | IPR009078 | |
| Domain | Pept_M10A_Zn_BS | 1.88e-03 | 15 | 81 | 2 | IPR021158 | |
| Domain | IBN_N | 1.88e-03 | 15 | 81 | 2 | PF03810 | |
| Domain | IBN_N | 2.14e-03 | 16 | 81 | 2 | SM00913 | |
| Domain | Importin-beta_N | 2.42e-03 | 17 | 81 | 2 | IPR001494 | |
| Domain | MetalloPept_cat_dom | 5.26e-03 | 81 | 81 | 3 | IPR024079 | |
| Domain | - | 5.26e-03 | 81 | 81 | 3 | 3.40.390.10 | |
| Pubmed | Class I HDAC activity is required for renal protection and regeneration after acute kidney injury. | 5.23e-08 | 4 | 83 | 3 | 24808536 | |
| Pubmed | Expression profile of class I histone deacetylases in human cancer tissues. | 5.23e-08 | 4 | 83 | 3 | 17786334 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 35062057 | ||
| Pubmed | Class I histone deacetylase activity is required for proliferation of renal epithelial cells. | 5.23e-08 | 4 | 83 | 3 | 23698124 | |
| Pubmed | Expression of class I histone deacetylases during chick and mouse development. | 5.23e-08 | 4 | 83 | 3 | 20979029 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 28497810 | ||
| Pubmed | Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. | 1.31e-07 | 5 | 83 | 3 | 27420561 | |
| Pubmed | HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. | 1.31e-07 | 5 | 83 | 3 | 31097476 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 12661033 | ||
| Pubmed | MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding. | 1.31e-07 | 5 | 83 | 3 | 29196321 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 26679995 | ||
| Pubmed | MYBBP1A MDN1 AARS2 PRPF4 FANCI CANX USP7 SCRIB VCP HDAC1 KPNB1 | 3.55e-07 | 638 | 83 | 11 | 33239621 | |
| Pubmed | Class I histone deacetylases in retinal progenitors and differentiating ganglion cells. | 4.56e-07 | 7 | 83 | 3 | 30179675 | |
| Pubmed | Membrane-type matrix metalloproteinases: Their functions and regulations. | 4.56e-07 | 7 | 83 | 3 | 25794647 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 11533236 | ||
| Pubmed | POLR1F HDAC3 SETD2 MYBBP1A MDN1 UBR5 PRPF4 FANCI USP7 NCAPH MED13 VCP HDAC1 | 8.17e-07 | 1014 | 83 | 13 | 32416067 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 15367668 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 26221039 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 12711221 | ||
| Pubmed | Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3'-end processing. | 1.55e-06 | 10 | 83 | 3 | 17172643 | |
| Pubmed | DPF1 SETD2 UBR5 PRPF4 ENTR1 APBA2 ADNP2 USP7 SCRIB ABCA7 SLC39A7 VCP HDAC1 | 2.35e-06 | 1116 | 83 | 13 | 31753913 | |
| Pubmed | 3.61e-06 | 653 | 83 | 10 | 22586326 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | POLR1F UBR5 PRPF4 FANCI KCTD10 APBA2 USP7 SCRIB F7 DCAF4 SLC39A7 VCP | 4.67e-06 | 1005 | 83 | 12 | 19615732 |
| Pubmed | Histone deacetylase expression patterns in developing murine optic nerve. | 4.68e-06 | 14 | 83 | 3 | 25011550 | |
| Pubmed | Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. | 4.68e-06 | 14 | 83 | 3 | 15537544 | |
| Pubmed | 5.21e-06 | 399 | 83 | 8 | 37536630 | ||
| Pubmed | Alcohol-induced serotonergic modulation: the role of histone deacetylases. | 5.63e-06 | 2 | 83 | 2 | 22796363 | |
| Pubmed | Histone deacetylases and the immunological network: implications in cancer and inflammation. | 5.63e-06 | 2 | 83 | 2 | 19855430 | |
| Pubmed | HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. | 5.63e-06 | 2 | 83 | 2 | 27550312 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30552140 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24805197 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7559440 | ||
| Pubmed | Insights into the activation mechanism of class I HDAC complexes by inositol phosphates. | 5.63e-06 | 2 | 83 | 2 | 27109927 | |
| Pubmed | Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. | 5.63e-06 | 2 | 83 | 2 | 22918830 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9070935 | ||
| Pubmed | 6.02e-06 | 288 | 83 | 7 | 23383273 | ||
| Pubmed | Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. | 7.18e-06 | 16 | 83 | 3 | 16873063 | |
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 10949577 | ||
| Pubmed | 1.04e-05 | 18 | 83 | 3 | 18824292 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | HDAC3 MYBBP1A UBR5 ITFG2 KLHDC3 FANCI MRPS24 ENTR1 USP7 EIPR1 POLQ SLC39A7 VCP | 1.07e-05 | 1284 | 83 | 13 | 17353931 |
| Pubmed | CNTN4 RELN MIA2 NECAB1 CNST APBA2 ADNP2 USP7 SCRIB MED13 VCP PCNT KPNB1 | 1.08e-05 | 1285 | 83 | 13 | 35914814 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 1.51e-05 | 220 | 83 | 6 | 31822558 | |
| Pubmed | MYBBP1A AMER1 UBR5 PRPF4 CANX MRPS24 ENTR1 APBA2 BYSL USP7 VCP HDAC1 KPNB1 | 1.61e-05 | 1335 | 83 | 13 | 29229926 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30279482 | ||
| Pubmed | HDAC1/2 and HDAC3 play distinct roles in controlling adult Meibomian gland homeostasis. | 1.69e-05 | 3 | 83 | 2 | 38679196 | |
| Pubmed | Poly(A) binding protein (PABP) homeostasis is mediated by the stability of its inhibitor, Paip2. | 1.69e-05 | 3 | 83 | 2 | 16601676 | |
| Pubmed | USP7 and VCPFAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork. | 1.69e-05 | 3 | 83 | 2 | 34644576 | |
| Pubmed | CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway. | 1.69e-05 | 3 | 83 | 2 | 21262769 | |
| Pubmed | Regulation of the HIF-1alpha stability by histone deacetylases. | 1.69e-05 | 3 | 83 | 2 | 17273746 | |
| Pubmed | STAT3 repressed USP7 expression is crucial for colon cancer development. | 1.69e-05 | 3 | 83 | 2 | 22750444 | |
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. | 1.69e-05 | 3 | 83 | 2 | 19099586 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18212746 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 25412078 | ||
| Pubmed | Expression and subcellular distribution of imp13 are regulated in brain development. | 1.69e-05 | 3 | 83 | 2 | 23605716 | |
| Pubmed | HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis. | 1.69e-05 | 3 | 83 | 2 | 18619497 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10958676 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18854353 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20731616 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11553631 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 15590418 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33637599 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18347167 | ||
| Pubmed | The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. | 1.69e-05 | 3 | 83 | 2 | 23087373 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23213415 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20484017 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11358320 | ||
| Pubmed | Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. | 1.69e-05 | 3 | 83 | 2 | 15711539 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20049841 | ||
| Pubmed | A cancer cell metalloprotease triad regulates the basement membrane transmigration program. | 1.69e-05 | 3 | 83 | 2 | 16983145 | |
| Pubmed | Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. | 1.69e-05 | 3 | 83 | 2 | 24821725 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9119382 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18501342 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18789002 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 32591593 | ||
| Pubmed | HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. | 1.69e-05 | 3 | 83 | 2 | 27342975 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33851097 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23475113 | ||
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma. | 1.69e-05 | 3 | 83 | 2 | 20415600 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21406501 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21972094 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33670166 | ||
| Pubmed | Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. | 1.69e-05 | 3 | 83 | 2 | 11006275 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26410369 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 37040767 | ||
| Pubmed | Molecular determinants of PAM2 recognition by the MLLE domain of poly(A)-binding protein. | 1.69e-05 | 3 | 83 | 2 | 20096703 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21179472 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | POLR1F MYBBP1A MDN1 UBR5 MAP4K3 FANCI BYSL ADNP2 USP7 SCRIB NCAPH VCP KPNB1 | 1.85e-05 | 1353 | 83 | 13 | 29467282 |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 1.95e-05 | 22 | 83 | 3 | 23421805 | |
| Pubmed | 1.95e-05 | 22 | 83 | 3 | 10419448 | ||
| Pubmed | MYBBP1A MDN1 MIA2 UBR5 CNST FANCI CANX BYSL NCAPH MED13 PCNT KPNB1 | 2.09e-05 | 1168 | 83 | 12 | 19946888 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 2.21e-05 | 639 | 83 | 9 | 23443559 | |
| Pubmed | 2.50e-05 | 496 | 83 | 8 | 31343991 | ||
| Pubmed | 2.56e-05 | 24 | 83 | 3 | 15734845 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.68e-05 | 363 | 83 | 7 | 14691545 | |
| Pubmed | Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression. | 3.27e-05 | 26 | 83 | 3 | 23506836 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 15192014 | ||
| Pubmed | Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3. | 3.37e-05 | 4 | 83 | 2 | 21059642 | |
| Pubmed | Inactivation of CREB mediated gene transcription by HDAC8 bound protein phosphatase. | 3.37e-05 | 4 | 83 | 2 | 19070599 | |
| Pubmed | The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. | 3.37e-05 | 4 | 83 | 2 | 34331453 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 9346952 | ||
| Interaction | FOXL1 interactions | 1.47e-06 | 196 | 83 | 8 | int:FOXL1 | |
| Cytoband | 6p21.1 | 1.41e-05 | 80 | 83 | 4 | 6p21.1 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.19e-07 | 4 | 57 | 3 | 989 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 5.74e-05 | 24 | 57 | 3 | 891 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.45e-03 | 18 | 57 | 2 | 596 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 1.37e-05 | 454 | 83 | 9 | M19927 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 3.09e-05 | 189 | 83 | 6 | M3112 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 3.90e-05 | 197 | 83 | 6 | M6512 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 4.12e-05 | 199 | 83 | 6 | M4142 | |
| Coexpression | GSE17580_TREG_VS_TEFF_UP | 4.24e-05 | 200 | 83 | 6 | M3670 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.62e-05 | 40 | 81 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-04 | 385 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.36e-04 | 397 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.41e-04 | 69 | 81 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.49e-04 | 209 | 81 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.94e-04 | 75 | 81 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 2.55e-04 | 231 | 81 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.55e-04 | 231 | 81 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.67e-04 | 330 | 81 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 169 | 83 | 5 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 169 | 83 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 169 | 83 | 5 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 172 | 83 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-05 | 186 | 83 | 5 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.69e-05 | 188 | 83 | 5 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.76e-05 | 189 | 83 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 192 | 83 | 5 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 193 | 83 | 5 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.13e-05 | 194 | 83 | 5 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.21e-05 | 195 | 83 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.21e-05 | 195 | 83 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 195 | 83 | 5 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 3.62e-05 | 200 | 83 | 5 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 3.62e-05 | 200 | 83 | 5 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 200 | 83 | 5 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 51 | 83 | 3 | 28d6b12c44ad308560931d275e0dd0243a555bf3 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.82e-04 | 151 | 83 | 4 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-04 | 152 | 83 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 162 | 83 | 4 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 165 | 83 | 4 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 165 | 83 | 4 | c042cde64b61ae195e1054f7b560151dabbfdf0d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 165 | 83 | 4 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 165 | 83 | 4 | a5c3af634d2698f9a01cf074791756b7669f9fff | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 166 | 83 | 4 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 167 | 83 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 167 | 83 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 170 | 83 | 4 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 170 | 83 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 171 | 83 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 171 | 83 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 171 | 83 | 4 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 172 | 83 | 4 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 172 | 83 | 4 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 3.06e-04 | 173 | 83 | 4 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 83 | 4 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 83 | 4 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 174 | 83 | 4 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | ASK452-Immune-NK_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.13e-04 | 174 | 83 | 4 | b84e6dc1c003a677234ce3a818650ff58a45dd09 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 3.13e-04 | 174 | 83 | 4 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 175 | 83 | 4 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 175 | 83 | 4 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 175 | 83 | 4 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 175 | 83 | 4 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-04 | 175 | 83 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-04 | 175 | 83 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-04 | 175 | 83 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 177 | 83 | 4 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 178 | 83 | 4 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-04 | 179 | 83 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.48e-04 | 179 | 83 | 4 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 3.63e-04 | 181 | 83 | 4 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-04 | 182 | 83 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 3.71e-04 | 182 | 83 | 4 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-04 | 182 | 83 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-04 | 182 | 83 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-04 | 183 | 83 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.95e-04 | 185 | 83 | 4 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 3.95e-04 | 185 | 83 | 4 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.03e-04 | 186 | 83 | 4 | 993c58ef4445bf81bbc9b489635883848b5b4c8e | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 186 | 83 | 4 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 187 | 83 | 4 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.28e-04 | 189 | 83 | 4 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.28e-04 | 189 | 83 | 4 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 189 | 83 | 4 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-04 | 189 | 83 | 4 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 190 | 83 | 4 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-04 | 190 | 83 | 4 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 4.36e-04 | 190 | 83 | 4 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 4.36e-04 | 190 | 83 | 4 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-04 | 190 | 83 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.36e-04 | 190 | 83 | 4 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 190 | 83 | 4 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-04 | 191 | 83 | 4 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Cycling_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.45e-04 | 191 | 83 | 4 | 5d4fed25bd318472a17228b12ade4c331865bda5 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-04 | 191 | 83 | 4 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.45e-04 | 191 | 83 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.54e-04 | 192 | 83 | 4 | 3856c4d611224cd6c2558631147cd5333bc0ccb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-04 | 193 | 83 | 4 | 43ffa8ecc72bebcd204279db2bde98ae48d97f90 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 193 | 83 | 4 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.63e-04 | 193 | 83 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.63e-04 | 193 | 83 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-04 | 193 | 83 | 4 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 193 | 83 | 4 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 193 | 83 | 4 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.63e-04 | 193 | 83 | 4 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.63e-04 | 193 | 83 | 4 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-04 | 194 | 83 | 4 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.72e-04 | 194 | 83 | 4 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.72e-04 | 194 | 83 | 4 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.72e-04 | 194 | 83 | 4 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| Drug | Rodeo | 3.77e-07 | 17 | 83 | 4 | CID000038078 | |
| Drug | Vorinostat | 4.65e-07 | 5 | 83 | 3 | DB02546 | |
| Drug | AC1MQZ6I | 6.13e-06 | 190 | 83 | 7 | CID003509873 | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 6615_DN | |
| Drug | Pimelic Acids | 1.31e-05 | 2 | 83 | 2 | ctd:D010867 | |
| Drug | AC1NV99J | 2.53e-05 | 16 | 83 | 3 | CID005474719 | |
| Drug | MMI270 | 3.66e-05 | 18 | 83 | 3 | CID000446504 | |
| Drug | AC1L1EXH | 3.66e-05 | 18 | 83 | 3 | CID000002992 | |
| Drug | trapoxin B | 3.93e-05 | 3 | 83 | 2 | ctd:C067071 | |
| Drug | 5,6-dimethyl-1,10-phenanthroline | 3.93e-05 | 3 | 83 | 2 | CID000076357 | |
| Disease | susceptibility to mononucleosis measurement | 9.50e-04 | 69 | 82 | 3 | EFO_0008403 | |
| Disease | colorectal cancer (is_marker_for) | 9.77e-04 | 157 | 82 | 4 | DOID:9256 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.01e-03 | 17 | 82 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.07e-03 | 72 | 82 | 3 | DOID:9744 (is_marker_for) | |
| Disease | Bardet-Biedl syndrome | 1.13e-03 | 18 | 82 | 2 | cv:C0752166 | |
| Disease | diabetes mellitus (biomarker_via_orthology) | 1.27e-03 | 19 | 82 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.46e-03 | 80 | 82 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | quinolinic acid measurement | 1.55e-03 | 21 | 82 | 2 | EFO_0010528 | |
| Disease | Down syndrome (is_marker_for) | 1.70e-03 | 22 | 82 | 2 | DOID:14250 (is_marker_for) | |
| Disease | prostate cancer, disease progression measurement | 2.02e-03 | 24 | 82 | 2 | EFO_0008336, MONDO_0008315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HVHEEEGILVAVGQD | 421 | Q8WV16 | |
| GGAAGRSHHLDEDEE | 276 | Q9H3F6 | |
| GEEAAGGDRLIHEQD | 66 | O43598 | |
| HTHLAEEEGEENAER | 216 | Q92782 | |
| NGHLIDFDRDGDHFE | 536 | Q8IWV2 | |
| HDGLSEAAHGPEDVV | 96 | Q5JTC6 | |
| EGQDHGKEDDHDSSI | 281 | Q9NZW4 | |
| EPSVLEAHDQEEDGH | 171 | Q99767 | |
| LLDHGAEVNHEDVDG | 696 | Q9ULJ7 | |
| GHIDVVQVLLEHGAD | 1056 | Q9ULJ7 | |
| EHEDGHILHAGSQDS | 246 | O95813 | |
| NDLVELAVGLSHGDH | 266 | Q6ZW61 | |
| GEGEGHHLQHISDRE | 56 | Q8N7R7 | |
| FGELAVHGAEHGVED | 2071 | Q8IZY2 | |
| PDGHLGAEDQRHGEE | 981 | Q6IQ32 | |
| EDVIINGHSHEDDNP | 16 | Q9BPZ3 | |
| DHIHICDGSEEENGR | 41 | P35558 | |
| DLELHLGALHGQEDT | 326 | Q5T089 | |
| QDIHGHLGDIDQDVE | 1051 | Q9NVI1 | |
| HDGNDLFLVAVHELG | 271 | Q9Y5R2 | |
| RGHVAHLEDDEGDDD | 406 | Q8IVH8 | |
| ADDQDGDAAQHPEEH | 4961 | Q9NU22 | |
| EDAVEALIGSGHHGA | 136 | Q8NHW3 | |
| GHLEGADAGEEDLEQ | 131 | Q9NPA3 | |
| IHDHENGAEDSNVAL | 376 | Q8IW41 | |
| LYIDIDIHHGDGVEE | 171 | Q13547 | |
| EHLEPSHDAGREEAA | 676 | Q9H8L6 | |
| GLGVAAEDAEVHAEN | 41 | P51511 | |
| DDHSEGGLVENHVDS | 151 | P18065 | |
| HDNESEEEGGLLHIP | 756 | A7KAX9 | |
| EDEAGLHQSQAVHGL | 231 | O95613 | |
| GHLVDDDDISDQEDH | 311 | Q53HC9 | |
| YIDIDIHHGDGVQEA | 166 | O15379 | |
| LDASGHHETLIGEEQ | 101 | Q969R8 | |
| HDLGERAGALHAQVE | 891 | Q9BQG0 | |
| THHGELEGDGEQGEV | 41 | P78509 | |
| HEEAEEDHQGVGLRG | 166 | Q8NC74 | |
| IDGGHAVDAAAIQDE | 346 | Q99999 | |
| AISEHVEDAGVHSGD | 1191 | P31327 | |
| QAAHKEEDPGHALEE | 216 | P52951 | |
| GHDVLRADSHEGEVA | 261 | Q99704 | |
| HGTHFGDDRFEDLEE | 91 | Q96C92 | |
| PVLDEHHQGDQDGGD | 1596 | O75417 | |
| HHQGDQDGGDQDERA | 1601 | O75417 | |
| GESHDHDQLNDTALE | 926 | A8TX70 | |
| DEELEHHDIGLDHDA | 176 | Q99807 | |
| AIVEAHDGHDDDVID | 16 | P27824 | |
| GHEAVELGHGEANIT | 756 | Q6ZUT9 | |
| IDHIAGDEDHTDGVV | 801 | Q14974 | |
| VEEGHTHDILAAGFD | 306 | Q5VSG8 | |
| GLGDEFDLIDHSDLH | 316 | Q9BQ90 | |
| DLDLHHGDGVEDAFS | 176 | Q9BY41 | |
| QQHLHGSGEEEEEEE | 41 | Q9BQA5 | |
| LGTGFSDEELEEHHQ | 796 | P18858 | |
| HIGQHQFGEDLILED | 3111 | Q92736 | |
| LDISHHEDDHEGPEL | 651 | O94829 | |
| AAGHHAEVVVDPEDE | 116 | Q13895 | |
| SDENENQLDGDGHEH | 36 | Q6PJW8 | |
| ENIQERAGGVHHDID | 621 | Q8N4N8 | |
| DAERVLAQADHELHG | 61 | Q53GL7 | |
| ESPEQEGAEGHFDLH | 401 | Q99983 | |
| KNEEDGGADEHEHPL | 401 | Q96PC5 | |
| GGADEHEHPLTSELD | 406 | Q96PC5 | |
| DHGEAHVQTDIALGV | 516 | Q5HYA8 | |
| LHTGNLDGEDHAAER | 71 | Q96EL2 | |
| DELHHGFTGLDLEEQ | 221 | A2RUB1 | |
| AHIQQLSEAAGEDDH | 21 | A6NDU8 | |
| DLEAQEEILHQEGHS | 351 | O43172 | |
| AVLGEHDLSEHDGDE | 266 | P08709 | |
| LEVNGVALQGAEHHE | 781 | Q14160 | |
| HRHQGHGIEEDEDVS | 271 | P23327 | |
| EKGTHHGSRDQEDEE | 506 | P23327 | |
| FADLIHHDLSEEEDG | 91 | Q9UHV7 | |
| AGGHHNDLEDVGRDL | 111 | Q5JTZ9 | |
| GAESQLDEDEHGLHT | 481 | O43734 | |
| NDEPDHTAVGDHEEF | 376 | Q15003 | |
| HAGHDREDGELEDGE | 6 | P61129 | |
| DGNDLFLVAVHELGH | 236 | P51512 | |
| LEQVANETHGHVGAD | 396 | P55072 | |
| AGLGGHDDLHDDLQE | 26 | Q92504 | |
| GAGVTLHEALEAADH | 511 | Q9H0I9 | |
| ELGDIYDDQGHIHLN | 101 | Q3B726 | |
| LDERGEGGHVHTSDD | 981 | Q9BYW2 | |
| EEAIEHNYGGHDDDL | 491 | Q93009 | |
| EGVAGEEDHHDEQEE | 1576 | O95071 | |
| HGEENAEAEGQHDEH | 1591 | O95071 | |
| DDPGEQVLSHAHEQE | 131 | Q3MJ62 | |
| ADGVLSGEELHELFH | 56 | Q8N987 |